Abbott Laboratories (BVMF:ABTT34)

Market Cap	1.23T
Revenue (ttm)	234.89B
Net Income (ttm)	75.89B
Shares Out	n/a
EPS (ttm)	43.44
PE Ratio	16.20
Forward PE	23.38
Dividend	0.74 (1.25%)
Ex-Dividend Date	Jul 14, 2025

Volume	2
Average Volume	1,267
Open	60.12
Previous Close	59.10
Day's Range	59.52 - 60.12
52-Week Range	49.20 - 67.65
Beta	0.73
RSI	45.74
Earnings Date	Jul 17, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ABTT34

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD